Status:
COMPLETED
Contextualizing & Responding to HIV Risk Behaviors
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Human Immunodeficiency Virus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of a an adapted group-based, multi-session, community-based Antiretroviral Therapy (ART...
Detailed Description
Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders postrelease, this po...
Eligibility Criteria
Inclusion
- ≥18 years of age
- HIV seropositive with "detectable" viral load (VL)(defined as \>50 copies/mL)
- history of drug use (used illicit drugs within the past year)
- experienced incarceration in prison or jail within the past five years
Exclusion
- living in a healthcare or assisted living facility
- experienced incarceration longer than five years ago
Key Trial Info
Start Date :
July 5 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 21 2016
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03300908
Start Date
July 5 2016
End Date
December 21 2016
Last Update
October 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032